Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 5/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39303 | 0.87 | ALDH1A1 (0.48) | ALDH1A1KDM4EALOX5SMN1; SMN2HPGD | |
| SCHEMBL39304 | 0.87 | ALDH1A1 (0.48) | ALDH1A1KDM4EALOX5SMN1; SMN2HPGD | |
| SCHEMBL156437 | 0.83 | TDP1 (0.50) | HDAC8ALDH1A1KDM4EALOX5TSHR | |
| SCHEMBL288562 | 0.83 | TDP1 (0.50) | HDAC8ALDH1A1KDM4EALOX5TSHR | |
| SCHEMBL5494926 | 0.82 | PTGER1 (0.37) | HDAC8HCAR2ALDH1A1KDM4EALOX5 | |
| SCHEMBL28629258 | 0.81 | APP (0.47) | APPHDAC8HCAR2ALDH1A1KDM4E | |
| SCHEMBL990905 | 0.81 | ALOX5 (0.41) | ALDH1A1KDM4EALOX5AKR1B10AKR1B1 | |
| SCHEMBL31279789 | 0.81 | APP (0.51) | APPHCAR2ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL5960780 | 0.80 | APP (0.41) | APPALDH1A1KDM4EALOX5LMNA | |
| SCHEMBL15665995 | 0.79 | APP (0.47) | APPHDAC8HCAR2ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12414909-B2 | Polysaccharide-based gelled foam | URGO RECHERCHE INNOVATION ET DEVELOPPEMENT (FR) | 2025-09-16 | — | — | US | disclosed |
| US-20220370329-A1 | POLYSACCHARIDE-BASED GELLED FOAM | URGO RECHERCHE INNOVATION ET DEVELOPPEMENT (FR) | 2022-11-24 | — | — | US | disclosed |
| EP-3544573-A1 | FILM-FORMING COMPOSITION | Urgo Recherche Innovation et Développement (FR) | 2019-10-02 | — | — | EP | disclosed |
| US-9642790-B2 | Aqueous dispersion of polymer particles, film-forming composition containing same and uses thereof | VIVATECH (FR) | 2017-05-09 | — | — | US | disclosed |
| US-9198998-B2 | Composition containing a cellulose, a vegetable oil and a volatile solvent, and use thereof as a dressing | LABORATORIES URGO (FR) | 2015-12-01 | — | — | US | disclosed |
| US-20150174042-A1 | AQUEOUS DISPERSION OF POLYMER PARTICLES, FILM-FORMING COMPOSITION CONTAINING SAME AND USES THEREOF | VIVATECH (FR) | 2015-06-25 | — | — | US | disclosed |
| US-20140154188-A1 | COMPOSITION CONTAINING A CELLULOSE, A VEGETABLE OIL AND A VOLATILE SOLVENT, AND USE THREOF AS A DRESSING | LABORATOIRES URGO (FR) | 2014-06-05 | — | — | US | disclosed |
| US-8741347-B2 | Method for forming cyclodextrin polymer and lipophilic compound emulsions, resulting emulsions, and compositions including said emulsions | Centre National de la Recherche Scientifique—CNRS (FR) | 2014-06-03 | — | — | US | disclosed |
| US-20140128468-A1 | TOPICAL FILM-FORMING COMPOSITION, AND USE THEREOF FOR TREATING MYCOSES | LABORATOIRES URGO (FR) | 2014-05-08 | — | — | US | disclosed |
| US-20120107252-A1 | METHOD FOR FORMING CYCLODEXTRIN POLYMER AND LIPOPHILIC COMPOUND EMULSIONS, RESULTING EMULSIONS, AND COMPOSITIONS INCLUDING SAID EMULSIONS | UNIVERSITE PARIS-SUD 11 (FR) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120107252-A1 | METHOD FOR FORMING CYCLODEXTRIN POLYMER AND LIPOPHILIC COMPOUND EMULSIONS, RESULTING EMULSIONS, AND COMPOSITIONS INCLUDING SAID EMULSIONS | LIPA, NOTUM, CEL | APP 133/4885HDAC8 3229/4885HCAR2 2665/4885 |
| US-20140128468-A1 | TOPICAL FILM-FORMING COMPOSITION, AND USE THEREOF FOR TREATING MYCOSES | CUTA, NACA, DPM1 | APP 957/4885HDAC8 2630/4885HCAR2 3972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.